A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the safety and tolerability of TD 4208, an
investigational drug being developed to treat people with moderate to very severe COPD,
compared to tiotropium.